Combined behavioral therapy and pharmacotherapy of agoraphobia.

Abstract

There are few controlled studies of combined behavioral-pharmacological treatments of agoraphobia with panic. This review of the empirical evidence from studies using exposure in vivo as the behavioral modality and imipramine as the pharmacological agent suggests that these treatments have mutually potentiating effects in this disorder.

• Authors: M Mavissakalian
• Journal: Journal of psychiatric research (J Psychiatr Res) Vol. 27 Suppl 1 Pg. 179-91 ( 1993) ISSN: 0022-3956 [Print] England
• PMID: 7908332 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S., Review)

Chemical References

• Imipramine

Topics

• Agoraphobia (psychology, therapy)
• Behavior Therapy
• Combined Modality Therapy
• Desensitization, Psychologic
• Follow-Up Studies
• Humans
• Imipramine (adverse effects, therapeutic use)
• Treatment Outcome